Galapagos Nv Share Price Today
(NASDAQ: GLPG)

Name: Galapagos Nv Share Price Today (NASDAQ: GLPG) - Galapagos Nv Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Galapagos Nv share price is $26.55 & ₹2,314.55 as on 13 Mar 2025, 19.08 hrs IST

$26.55

▲

0.92

(3.59%)

Market is closed - opens 7 PM, 13 Mar 2025

View live Galapagos Nv share price in Dollar and Rupees. Guide to invest in Galapagos Nv stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Galapagos Nv, along with analyst recommendations, forecasts, and comprehensive financials.

Galapagos Nv share price movements

Today's Low: $26.47
Today's High: $27.00
$26.55
0.32%
Downside
Day's Volatility :1.98%
Upside
1.67%
52 Weeks Low: $22.36
52 Weeks High: $34.68
$26.55
15.78%
Downside
52 Weeks Volatility :35.52%
Upside
23.44%

Galapagos Nv (GLPG) Returns

Period	Galapagos Nv	Sector (Health Care)	Index (Russel 2000)
3 Months	-1.59%	2.6%	0.0%
6 Months	-9.39%	-7.4%	0.0%
1 Year	-23.27%	-1.3%	0.0%
3 Years	-56.43%	12.1%	-10.6%

Galapagos Nv (GLPG) Key Statistics

in dollars & INR

Previous Close	$26.55
Open	$26.79
Today's High	$26.35
Today's Low	$26.1812
Market Capitalization	$1.7B
Today's Volume	$159.0K
52 Week High	$34.68
52 Week Low	$22.36
Revenue TTM	$275.6M
EBITDA	$-152.9M
Earnings Per Share (EPS)	$-0.02
Profit Margin	26.88%
Quarterly Earnings Growth YOY	0.75%
Return On Equity TTM	-0.05%

How to invest in Galapagos Nv Stock (GLPG) from India?

It is very easy for Indian residents to invest directly in Galapagos Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Galapagos Nv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Galapagos Nv or GLPG on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Galapagos Nv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Galapagos Nv shares which would translate to 0.033 fractional shares of Galapagos Nv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Galapagos Nv, in just a few clicks!

Returns in Galapagos Nv (GLPG) for Indian investors in Rupees

The Galapagos Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Galapagos Nv investment value today

Current value as on today

₹81,971

Returns

₹18,029

(-18.03%)

Returns from Galapagos Nv Stock

₹23,266 (-23.27%)

Dollar Returns

₹5,237 (+5.24%)

Indian investors sentiment towards Galapagos Nv (GLPG)

Period: Feb 10, 2025 to Mar 12, 2025. Change in 30 Days versus previous period

Search interest for Galapagos Nv Stock from India on INDmoney has increased by 0% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Galapagos Nv

TANG CAPITAL MANAGEMENT LLC
3.28%
FMR Inc
2.42%
Bvf Inc
2.38%
Deerfield Management Co
2.14%
Prosight Management, LP
1.56%
Deep Track Capital, LP
1.18%

Analyst Recommendation on Galapagos Nv

Hold

38%Buy

61%Hold

0%Sell

Based on 18 Wall street analysts offering stock ratings for Galapagos Nv(by analysts ranked 0 to 5 stars)

Based on 18 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Galapagos Nv Stock (GLPG)

What analysts predicted

Upside of 19.09%

Target:

$31.62

Current:

$26.55

Insights on Galapagos Nv Stock (Ticker Symbol: GLPG)

Price Movement
In the last 1 month, GLPG stock has moved up by 4.2%
Decreasing Revenue
Revenue is down for the last 2 quarters, 77.87M → 59.84M (in $), with an average decrease of 23.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 4 quarters, 157.55M → -50.43M (in $), with an average decrease of 264.7% per quarter
GLPG vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 63.3% return, outperforming this stock by 86.6%
GLPG vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 56.4% return, outperforming this stock by 112.0%
Price to Sales
ForGLPG every $1 of sales, investors are willing to pay $127.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

GLPG Galapagos Nv Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$328.6M	↑ 127.27%
Net Income	$-33.3M	↓ 74.71%
Net Profit Margin	-10.13%	↑ 80.91%

	FY19	Y/Y Change
Revenue	$939.0M	↑ 192.55%
Net Income	$166.5M	↓ 612.13%
Net Profit Margin	17.73%	↑ 27.86%

	FY20	Y/Y Change
Revenue	$581.5M	↓ 43.42%
Net Income	$-378.3M	↓ 307.55%
Net Profit Margin	-65.06%	↓ 82.79%

	FY21	Y/Y Change
Revenue	$548.1M	↑ 1.42%
Net Income	$-141.8M	↓ 59.67%
Net Profit Margin	-25.87%	↑ 39.19%

	FY22	Y/Y Change
Revenue	$534.7M	↑ 4.21%
Net Income	$-230.7M	↑ 73.81%
Net Profit Margin	-43.14%	↓ 17.27%

	FY23	Y/Y Change
Revenue	$261.5M	↓ 52.56%
Net Income	$230.9M	↓ 197.11%
Net Profit Margin	88.31%	↑ 131.45%

	Q2 FY23	Q/Q Change
Revenue	$162.7M	↓ 16.17%
Net Income	$5.5M	↓ 78.02%
Net Profit Margin	3.4%	↓ 9.57%

	Q3 FY23	Q/Q Change
Revenue	$128.1M	↓ 19.96%
Net Income	$27.6M	↑ 406.37%
Net Profit Margin	21.52%	↑ 18.12%

	Q4 FY23	Q/Q Change
Revenue	$-228.1M	↓ 274.23%
Net Income	$171.9M	↑ 509.98%
Net Profit Margin	-75.34%	↓ 96.86%

	Q1 FY24	Q/Q Change
Revenue	$67.9M	↓ 129.85%
Net Income	$98.1M	↓ 42.74%
Net Profit Margin	144.51%	↑ 219.85%

	Q2 FY24	Q/Q Change
Revenue	$83.8M	↑ 24.73%
Net Income	$9.7M	↓ 90.04%
Net Profit Margin	11.54%	↓ 132.97%

	Q3 FY24	Q/Q Change
Revenue	$59.8M	↓ 23.15%
Net Income	$-50.4M	↓ 661.27%
Net Profit Margin	-84.26%	↓ 95.8%

	FY18	Y/Y Change
Profit	$-38.7M	↓ 62.76%

	FY19	Y/Y Change
Profit	$464.1M	↓ 1326.99%

	FY20	Y/Y Change
Profit	$-55.5M	↓ 110.92%

	FY21	Y/Y Change
Profit	$546.3M	↓ 1159.36%

	FY22	Y/Y Change
Profit	$521.9M	↑ 2.07%

	FY23	Y/Y Change
Profit	$222.3M	↓ 58.69%

	Q2 FY23	Q/Q Change
Profit	$158.0M	↓ 16.89%

	Q3 FY23	Q/Q Change
Profit	$122.0M	↓ 21.52%

	Q4 FY23	Q/Q Change
Profit	$-320.2M	↓ 356.76%

	Q1 FY24	Q/Q Change
Profit	$65.1M	↓ 120.4%

	Q2 FY24	Q/Q Change
Profit	$66.0M	↑ 2.39%

	Q3 FY24	Q/Q Change
Profit	$59.8M	↓ 2.42%

	FY18	Y/Y Change
Operating Cash Flow	$-162.1M	↓ 3.1%
Investing Cash Flow	$-18.1M	↑ 2798.72%
Financing Cash Flow	$327.5M	↓ 18.53%

	FY19	Y/Y Change
Operating Cash Flow	$3.6B	↓ 2352.2%
Investing Cash Flow	$-4.2B	↑ 23556.28%
Financing Cash Flow	$1.5B	↑ 364.0%

	FY20	Y/Y Change
Operating Cash Flow	$-519.8M	↓ 113.32%
Investing Cash Flow	$921.1M	↓ 120.12%
Financing Cash Flow	$26.8M	↓ 98.35%

	FY21	Y/Y Change
Operating Cash Flow	$-569.6M	↑ 17.9%
Investing Cash Flow	$611.8M	↓ 28.53%
Financing Cash Flow	$-4.4M	↓ 117.59%

	FY22	Y/Y Change
Operating Cash Flow	$-529.7M	↓ 0.65%
Investing Cash Flow	$-1.3B	↓ 330.12%
Financing Cash Flow	$-1.6M	↓ 61.64%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-136.0M	↑ 32.2%
Investing Cash Flow	$198.0M	↑ 0.0%
Financing Cash Flow	$-1.7M	↑ 716.32%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$-126.8M	↓ 5.26%
Investing Cash Flow	$194.9M	↑ 0.0%
Financing Cash Flow	$-2.2M	↑ 33.4%

Galapagos Nv Technicals Summary

Sell

Neutral

Buy

Galapagos Nv is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Galapagos Nv (GLPG) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Galapagos Nv	14.0%	-9.39%	-23.27%	-56.43%	-83.51%
Regeneron Pharmaceuticals, Inc.	3.61%	-40.79%	-28.58%	5.04%	56.41%
Beone Medicines Ltd	12.94%	27.29%	41.58%	70.27%	78.46%
Vertex Pharmaceuticals Incorporated	8.83%	3.5%	19.9%	104.99%	148.0%
Alnylam Pharmaceuticals, Inc.	-9.87%	-7.37%	63.34%	59.7%	146.62%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Galapagos Nv	50.85	NA	0.0	-0.54	0.0	-0.03	NA	43.96
Regeneron Pharmaceuticals, Inc.	18.73	18.73	1.06	42.83	0.16	0.07	0.0	273.57
Beone Medicines Ltd	NA	NA	NA	1.45	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.4	18.06	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.52	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Galapagos Nv	Hold	$1.7B	-83.51%	50.85	26.88%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	56.41%	18.73	31.07%
Beone Medicines Ltd	NA	$28.3B	78.46%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$127.2B	148.0%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$30.9B	146.62%	NA	-12.37%

About Galapagos Nv

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Organization	Galapagos Nv
Employees	0
CEO	Dr. Paulus A. Stoffels M.D., Ph.D.
Industry	Health Technology

Management People of Galapagos Nv

Name	Title
Dr. Paulus A. Stoffels M.D., Ph.D.	CEO, Chairman, Interim Head of R&D
Mr. Thad Huston C.M.A.	Executive VP, CFO & COO
Ms. Sofie Van Gijsel	Head of Investor Relations
Ms. Valeria Cnossen	Executive VP & General Counsel
Marieke Vermeersch	Head of Corporate Communication
Ms. Annelies Missotten	Executive VP & Chief Human Resources Officer
Ms. Ellen Van Der Aar	Head of Development
Mr. Philippe Alen M.B.A., Ph.D., Pharm.D.	Senior VP & Head of Business Development
Ms. Alice Dietrich	Head of Medical Affairs
Dr. Pierre J.M.B. Raboisson Ph.D., Pharm.D.	Head of Small Molecules Discovery & Senior VP

Important FAQs about investing in GLPG Stock from India :

What is Galapagos Nv share price today?

Galapagos Nv share price today stands at $26.55, Open: $26.79 ; Previous Close: $25.63 ; High: $27.00 ; Low: $26.47 ; 52 Week High: $34.68 ; 52 Week Low: $22.36.

The stock opens at $26.79, after a previous close of $25.63. The stock reached a daily high of $27.00 and a low of $26.47, with a 52-week high of $34.68 and a 52-week low of $22.36.

Can Indians buy Galapagos Nv shares?

Yes, Indians can invest in the Galapagos Nv (GLPG) from India.

With INDmoney, you can buy Galapagos Nv at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Galapagos Nv at zero transaction cost.

How can I buy Galapagos Nv shares from India?

It is very easy to buy Galapagos Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Galapagos Nv (GLPG) be purchased?

Yes, you can buy fractional shares of Galapagos Nv with INDmoney app.

What are the documents required to start investing in Galapagos Nv stocks?

To start investing in Galapagos Nv, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.